Dipyridamole Alters Cardiac Substrate Preference by Inducing Translocation of FAT/CD36, but Not That of GLUT4

Molecular Pharmacology

Volumn 65, Issue 3, 2004, Pages 639-645

  Luiken, Joost J F P ^a   Coort, Susan L M ^a   Willems, Jodil ^a   Coumans, Will A ^a   Bonen, Arend ^b   Glatz, Jan F C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; CARDIOVASCULAR AGENT; CD36 ANTIGEN; DIPYRIDAMOLE; GLUCOSE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LONG CHAIN FATTY ACID; NUCLEOSIDE; OLIGOMYCIN; PALMITIC ACID DERIVATIVE; PHOSPHODIESTERASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; GLUCOSE TRANSPORT; HEART CONTRACTION; HEART MUSCLE CELL; INSULIN RESPONSE; LIPID TRANSPORT; MALE; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; SARCOLEMMA; SIGNAL TRANSDUCTION;

ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD36; BIOLOGICAL TRANSPORT; DIPYRIDAMOLE; ENZYME ACTIVATION; GLUCOSE TRANSPORTER TYPE 4; HEART; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; MULTIENZYME COMPLEXES; MUSCLE PROTEINS; MYOCARDIUM; PLATELET AGGREGATION INHIBITORS; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, INBRED LEW;

EID: 1342287133     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.65.3.639     Document Type: Article

References (32)

1. Abdel-Aleem S, El-Guindy N, Sallam TI, Hughes GC and Lowe JE (1999) Stimulation of long-chain fatty acid uptake by dipyridamole in isolated myocytes. J Cardiovasc Pharmacol 33:43-48.
2. Beavo JA (1995) Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75:725-748.
3. Brinkmann JF, Abumrad NA, Ibrahimi A, van der Vusse GJ, and Glatz JFC (2002) New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36. Biochem J 367:561-570.
4. Coburn CT, Hajri T, Ibrahimi A, and Abumrad NA (2001) Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues. J Mol Neurosci 16:117-121.
5. Coort SLM, Willeras J, Coumans WA, van der Vusse GJ, Bonen A, Glatz JFC, and Luiken JJFP (2002) Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake. Mol Cell Biochem 239:213-219.
6. De Schryver EL, Algra A, and van Gijn J (2003) Cochrane review: dipyridamole for preventing major vascular events in patients with vascular disease. Stroke 34:2072-2080.
7. Endoh M, Yamashita S, and Taira N (1982) Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. J Pharmacol Exp Ther 221:775-783.
8. Fischer Y, Thomas J, Rosen P, and Kammermeier H (1995) Action of metformin on glucose transport and glucose transporter GLUT1 and GLUT4 in heart muscle cells from healthy and diabetic rats. Endocrinology 136:412-420.
9. Fischer Y, Thomas J, Sevilla L, Munoz P, Becker C, Holman G, Kozka IJ, Palacin M, Testar X, Kammermeier H, and Zorzano A (1997) Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations. J Biol Chem 272:7085-7092.
10. Gong GX, Weiss HR, Tse J, and Scholz PM (1997) Cyclic GMP decreases cardiac myocyte oxygen consumption to a greater extent under conditions of increased metabolism. J Cardiovasc Pharmacol 30:537-543.
11. Hammond JR, Williams EF, and Clanachan AS (1985) Affinity of calcium channel inhibitors, benzodiazepines and other vasoactive compounds for the nucleoside transport system. Can J Physiol Pharmacol 63:1302-1307.
12. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, and Goodyear LJ (1998) Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47:1369-1373.
13. Hue L, Beauloye C, Marsin AS, Bertrand L, Horman S, and Rider MH (2002) Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways. J Mol Cell Cardiol 34:1091-1097.
14. Humphreys DM, Street J, Schumacher H, Bertrand-Hardy JM, and Palluk R (2002) Dipyridamole may be used safely in patients with ischaemic heart disease. Int J Clin Pract 56:121-127.
15. Kalsi KK, Smolenski RT, and Yacoub MH (1998) Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes. Mol Cell Biochem 180:193-199.
16. Kandror KV and Pilch PF (1996) Compartmentalization of protein traffic in insulin-sensitive cells. Am J Physiol 271:E1-E14.
17. Komas N, Le Bec A, Stoclet JC, and Lugnier C (1991) Cardiac cGMP-stimulated cyclic nucleotide phosphodiesterases: effects of cGMP analogues and drugs. Eur J Pharmacol 206:5-13.
18. Luiken JJFP, van Nieuwenhoven FA, America G, van der Vusse GJ, and Glatz JFC (1997) Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: involvement of sarcolemmal proteins. J Lipid Res 38:745-758.
19. Luiken JJFP, Dyck DJ, Han XX, Tandon NN, Arumugam Y, Glatz JFC, and Bonen A (2002a) Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane. Am J Physiol 282:E491-E495.
20. Luiken JJFP, Koonen DPY, Willems J, Zorzano A, Becker C, Fischer Y, Tandon NN, Van Der Vusse GJ, Bonen A, and Glatz JFC (2002b) Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51:3113-3119.
21. Luiken JJFP, Willems J, Coort SLM, Coumans WA, Bonen A, Van Der Vusse GJ, and Glatz JFC (2002c) Effects of cAMP modulators on long-chain fatty-acid uptake and utilization by electrically stimulated rat cardiac myocytes. Biochem J 367:881-887.
22. Luiken JJFP, Coort SLM, Willems J, Coumans WA, Bonen A, van der Vusse GJ, and Glatz JFC (2003) Contraction-induced FAT/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52:1627-1634.
23. MacWalter RS and Shirley CP (2002) A benefit-risk assessment of agents used in the secondary prevention of stroke. Drug Saf 25:943-963.
24. Mainwaring RD and Mentzer RM Jr (1986) Effects of dipyridamole on myocardial glucose uptake in the newborn lamb. J Surg Res 40:528-533.
25. Park SH, Gammon SR, Knippers JD, Paulsen SR, Rubink DS, and Winder WW (2002) Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J Appl Physiol 92:2475-2482.
26. Pettigrew LC and Williams SC (2002) Antithrombotic drugs for prevention of recurrent stroke. J Ky Med Assoc 100:184-193.
27. Prasad RK, Behrooz A, and Ismail-Beigi F (1999) LY-83583 stimulates glucose transporter-1-mediated glucose transport independent of changes in cGMP levels. Eur J Pharmacol 366:101-109.
28. Russell RR 3rd, Bergeron R, Shulman GI, and Young LH (1999). Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 277:H643-H649.
29. Steinfelder HJ and Joost HG (1988) Inhibition of insulin-stimulated glucose transport in rat adipocytes by nucleoside transport inhibitors. FEBS Lett 227:215-219.
30. Van Belle H (1993) Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine? Cardiovasc Res 27:68-76.
31. Van der Vusse GJ, Coumans WA, van der Veen E, Drake AJ, Flameng W, and Suy R (1984) ATP, creatine phosphate and glycogen content in human myocardial biopsies: markers for the efficacy of cardioprotection during aorto-coronary bypass surgery. Vasc Surg 18:127-134.
32. Winder WW (2000) AMP-activated protein kinase: possible target for treatment of type 2 diabetes. Diabetes Technol Ther 2:441-448.